Photoallergy Clinical Trial
Official title:
A 6-Week, Randomized Study to Evaluate the Potential of MC2-01 Cream to Induce Photoallergic Skin Reaction in Healthy Subjects, Using a Controlled Photopatch Test Design
This trial is a 6-week, Randomized study evaluating the potential of MC2-01 Cream to induce a photoallergic skin reaction in Healthy subjects, using a controlled photopatch test design.
The study evaluates the potential of MC2-01(CAL/BDP 0.005/0.064 w/w%) Cream to induce a photoallergic skin reaction. Because MC2-01 Cream is formulated for topical use and has shown to absorb light within the range of natural sunlight, it is necessary to determine the potential of this product to cause a photoallergic reaction after application to the skin. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03812887 -
Photopatch Test Study (POST Study)
|
||
| Completed |
NCT02872220 -
To Test for Photo Allergy Reaction of Sunscreens
|
N/A |